Top 200A |
C/O 2024, Top 200A portion. Generic/Brand name |
Pharmacology |
2022-12-19 |
SPangKee |
99 |
1 |
edit |
|
Top 200A |
C/O 2024, Top 200A portion. Generic with pharm. category and indications |
Pharmacology |
2022-12-19 |
SPangKee |
99 |
1 |
edit |
|
Top 200A |
C/O 2024, Top 200A portion. Generic with Strengths and Formulations |
Pharmacology |
2022-12-19 |
SPangKee |
99 |
1 |
edit |
|
Block 2.3 |
Day 1: Dr. Riccio Hemostasis & Antithrombitics |
Pharmacology |
2022-09-26 |
SPangKee |
59 |
1 |
edit |
|
Block 2.3 |
Day 1: Dr. Clark Cardiovascular Physiology Review |
Pharmacology |
2022-09-23 |
SPangKee |
56 |
1 |
edit |
|
Block 2.3 |
Day 2: Dr. Riccio VTE |
Pharmacology |
2022-09-25 |
SPangKee |
47 |
1 |
edit |
|
Block 2.3 |
Day 3: Dr. Williams Hyperlipidemia |
Pharmacology |
2022-09-26 |
SPangKee |
77 |
1 |
edit |
|
Block 2.3 |
Day 4: Dr. Williams Hypertension |
Pharmacology |
2022-09-26 |
SPangKee |
60 |
1 |
edit |
|
Block 2.3 |
Day 5: Dr. Clark Hypertensive Crisis |
Pharmacology |
2022-09-28 |
SPangKee |
43 |
1 |
edit |
|